Nanox Vision

Medical Imaging Technology and Solutions

Health Tech & Life Sciences
Public on NASDAQ on Aug 2020
Follow

Company Overview

Snapshot

Founded in December 2018, Nanox Vision operates with 51–200 employees and has raised a total of $345 million across 7 funding rounds from 6 investors. The company went public on NASDAQ in August 2020, achieving a valuation of $1.2 billion.

Business overview

Nanox Vision is dedicated to advancing preventive healthcare through affordable medical imaging technologies, leveraging advanced AI and novel digital sources. The company's ecosystem includes Nanox.ARC, a cost-effective multi-source Digital Tomosynthesis system; Nanox.AI, an AI-based suite of algorithms for early disease detection from routine CT imaging; Nanox.CLOUD, a cloud-based platform for data management and imaging analysis; and Nanox.MARKETPLACE, a decentralized marketplace providing remote access to radiology and cardiology experts. Nanox aims to improve early detection and treatment globally, serving the health tech and life sciences sector.

Strategic signal

In November 2025, Nanox.AI's Bone Solutions, an advanced AI-powered software for spine assessment, received a recommendation from NICE for early value assessment in UK National Health Service hospitals. This endorsement signals significant market validation and potential for broader adoption of Nanox's AI diagnostic tools within major healthcare systems, indicating a strong forward trajectory for its AI solutions in clinical practice.

Log in to access full profile ›

Company Intelligence Q&A

What was a significant recent financial event for Nanox Vision?
In November 2025, Nanox Vision announced a $15 million registered direct offering of common stock.
What strategic partnership did Nanox Vision announce in September 2025?
In September 2025, Nanox Vision partnered with Monarch Medical Management in a multi-segment healthcare collaboration to expand access to advanced medical imaging, including 3D imaging.
What recognition did Nanox Vision receive in October 2024?
In October 2024, Nanox Vision was highlighted on TIME's Best Inventions of 2024 List for its AI Solutions, recognizing its innovative contributions to the field.
What was a key operational development for Nanox.AI in November 2025?
In November 2025, Nanox.AI Bone Solutions, an advanced AI-powered software for spine assessment, was recommended by NICE for early value assessment in UK National Health Service hospitals.
When did Nanox Vision go public?
Nanox Vision went public on NASDAQ in August 2020, achieving a valuation of $1.2 billion.
Log in to access full profile ›

External links